Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,133.72
(
-0.06%
)
US TECH 100
26,219.20
(
0.06%
)
Dow Jones
49,408.39
(
-0.16%
)
Brent Oil
100.15
(
3.55%
)
Bitcoin
77,831.21
(
-0.52%
)
News Focus
News Focus
Post# of 257439
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122884
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ronpopeil post# 238154

Wednesday, 05/26/2021 4:32:01 PM

Wednesday, May 26, 2021 4:32:01 PM

Post# of 257439
MYOV/PFE PR on FDA approval of Myfembree—(relugolix_combination_ tablet):

https://www.globenewswire.com/news-release/2021/05/26/2236871/0/en/Myovant-Sciences-and-Pfizer-Receive-FDA-Approval-for-MYFEMBREE-the-First-Once-Daily-Treatment-for-Heavy-Menstrual-Bleeding-Associated-With-Uterine-Fibroids.html

Based on the collaboration struck in Dec 2020 (#msg-160498061), MYOV and PFE will split profits 50/50 from US/Canada sales of Myfembree.

CC Friday at 8:30am ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today